Hybridoma Antibodies to the Murine Coronavirus JHM: Characterization of Epitopes on the Peplomer Protein (E2)

References

1. Baybutt H. N., Wege H., Carter M. J., Ter Meulen V. 1984; Adaptation of coronavirus JHM to persistentinfection of murine Sac(–) cells. Journal of General Virology 65:915–924
   [Google Scholar]
2. Bonner W. M., Laskey R. A. 1974; A film detection method for tritium-labeled proteins and nucleic acids inpolyacrylamide gels. European Journal of Biochemistry 46:83–88
   [Google Scholar]
3. Buchmeier M. J., Lewicki H. A., Talbot P. J., Knobler R. L. 1984; Murine hepatitis virus-4 (strain JHM)induced neurologic disease is modulated in vivo by monoclonal antibody. Virology 132:261–270
   [Google Scholar]
4. Collins A. R., Knobler R. L., Powell H., Buchmeier M. I. 1982; Monoclonal antibodies to murine hepatitisvirus-4 (strain JHM) define the viral glycoprotein responsible for attachment and cell-cell fusion. Virology 119:358–371
   [Google Scholar]
5. Cotton R. G. H., Secher D. S., Milstein C. 1973; Somatic mutation and the origin of antibody diversity. Clonal variability of the immunoglubulin produced by MOPC 21 cells in culture. European Journal of Immunology 3:135–140
   [Google Scholar]
6. Dörries R., Ter Meulen V. 1980; Detection of enterovirus specific IgG and IgM antibodies in humans by anindirect solid phase radioimmunoassay. Medical Microbiology and Immunology 168:159–171
   [Google Scholar]
7. Dörries R., Ter Meulen V. 1983; Specificity of the IgM response in acute human coxsackievirus B infections, analysed by indirect solid phase enzyme immunoassay and immunoblot technique. Journal of GeneralVirology 64:159–167
   [Google Scholar]
8. Fleming I. O., Stohlman S. A., Harmon R. C., Lai M. M. C., Frelinger J. A., Weiner L. P. 1983; Antigenicrelationships of murine coronaviruses: analysis using monoclonal antibodies to JHM (MHV-4) virus. Virology 131:296–307
   [Google Scholar]
9. Galfré G., Howe S. C., Milstein C., Butcher G. W., Howard J. C. 1977; Antibodies to major histocompatibility antigen produced by hybrid cell lines. Nature, London 266:550–552
   [Google Scholar]
10. Garwes D. J., Lucas M. H., Higgins D. A., Pike B. V., Cartwright S. F. 1978/1979; Antigenicity of structuralcomponents from porcine transmissible gastroenteritis virus. Veterinary Microbiology 3:179–190
    [Google Scholar]
11. Guesdon J. L., Ternynck T., Avrameas S. 1979; The use of avidin-biotin interaction in immunoenzymatic techniques. Journal of Histochemistry and Cytochemistry 27:1131–1139
    [Google Scholar]
12. Hasony H. J., MacNaughton M. R. 1981; Antigenicity of mouse hepatitis virus strain 3 subcomponents in C57strain mice. Archives of Virology 69:33–41
    [Google Scholar]
13. Holmes K. V., Doller E. W., Behnke J. N. 1981; Analysis of the functions of coronavirus glycoproteins bydifferential inhibition of synthesis with tunicamycin. In Biochemistry and Biology of Coronaviruses pp 133–142 Edited by Ter Meulen V., Siddell S., Wege H. New York & London: Plenum Press;
    [Google Scholar]
14. Kimura-Kuroda J., Yasui K. 1983; Topographical analysis of antigenic determinants on envelope glycoproteinV3 (E) of Japanese encephalitis virus, using monoclonal antibodies. Journal of Virology 45:124–132
    [Google Scholar]
15. Knobler R. L., Lampert P. W., Oldstone M. B. A. 1982; Virus persistence and recurring demyelinationproduced by a temperature-sensitive mutant of MHV-4. Nature, London 298:279–280
    [Google Scholar]
16. Laemmli U. K. 1970; Cleavage of structural protein during the assembly of the head of bacteriophage T4. Nature, London 111:680–685
    [Google Scholar]
17. Makino S., Taguchi F., Hayami M., Fujiwara K. 1983; Characterization of small plaque mutants of mousehepatitis virus, JHM strain. Microbiology and Immunology 27:445–454
    [Google Scholar]
18. Merz D.C., Scheid A., Choppin P. W. 1980; Importance of antibodies to the fusion glycoprotein ofparamyxoviruses in the prevention of spread of infection. Journal of Experimental Medicine 151:275–288
    [Google Scholar]
19. Nagashima K., Wege H., Meyermann R., Ter Meulen V. 1979; Demyelinating encephalomyelitis induced by along-term corona virus infection in rats. Acta neuropathologica 45:205–213
    [Google Scholar]
20. Niemann H., Boschek B., Evans D., Rosing M., Tamura T., Klenk H. D. 1982; Subcellular localization of the posttranslational glycosylation of coronavrius glycoproteins El. EMBO Journal 1:1499–1504
    [Google Scholar]
21. Scheid A., Choppin P. W. 1977; Two disulfide-linked polypeptide chains constitute the active F-protein ofparamyxoviruses. Virology 80:54–66
    [Google Scholar]
22. Schmidt O. W., Kenny G. E. 1982; Polypeptides and functions of antigens from human coronaviruses 229E andOC43. Infection and Immunity 35:515–522
    [Google Scholar]
23. Siddell S. G. 1982; Coronavirus JHM: tryptic peptide fingerprinting of virion proteins and intracellularpolypeptides. Journal of General Virology 62:259–269
    [Google Scholar]
24. Siddell S. G., Wege H., Barthel A., Ter Meulen V. 1980; Coronavirus JHM: cell-free synthesis of structuralprotein p60. Journal of Virology 33:10–17
    [Google Scholar]
25. Siddell S., Wege H., Barthel A., Ter Meulen V. 1981; Coronavirus JHM: intracellular protein synthesis. Journal of General Virology 53:145–155
    [Google Scholar]
26. Siddell S. G., Wege H., Ter Meulen V. 1983; The biology of coronaviruses. Journal of General Virology 64:761–776
    [Google Scholar]
27. Stephenson J. R., Ter Meulen V. 1979; Antigenic relationships between measles and canine distemper viruses:comparison of the immune response in animals and humans to individual virus-specific polypeptides. Proceedings of the National Academy of Sciences, U. S. A 76:6601–6605
    [Google Scholar]
28. Stohlman S. A., Weiner L. P. 1981; Chronic central nervous system demyelination in mice after JHM virusinfection. Neurology 31:38–44
    [Google Scholar]
29. Stone M. R., Nowinski R. C. 1980; Topological mapping of murine leukemia virus proteins by competition-binding assays with monoclonal antibodies. Virology 100:370–381
    [Google Scholar]
30. Storz J., Rott R., Kaluza G. 1981; Enhancement of plaque formation and cell fusion of an enteropathogeniccoronavirus by trypsin treatment. Infection and Immunity 31:1214–1222
    [Google Scholar]
31. Sturman L. S., Holmes K. V. 1983; The molecular biology of coronaviruses. Advances in Virus Research 28:35–111
    [Google Scholar]
32. Sturman L. S., Holmes K. V., Behnke I. 1980; Isolation of coronavirus envelope glycoproteins and interactionwith the viral nucleocapsid. Journal of Virology 33:449–462
    [Google Scholar]
33. Talbot P. J., Salmi A. A., Knobler R. L., Buchmeier M. J. 1984; Topographical mapping of epitopes on theglycoproteins of murine hepatitis virus-4 (strain JHM): correlation with biological activities. Virology 132:250–260
    [Google Scholar]
34. Watanabe R., Wege H., Ter Meulen V. 1983; Adoptive transfer of EAE-like lesions by BMP stimulatedlymphocytes from rats with coronavirus-induced demyelinating encephalomyelitis. Nature, London 305:150–153
    [Google Scholar]
35. Wege H., Wege H., Nagashima K., Ter Meulen V. 1979; Structural polypeptides of the murine coronavirusJHM. Journal of General Virology 42:37–47
    [Google Scholar]
36. Wege H., Siddell S., Ter Meulen V. 1982; The biology and pathogenesis of coronaviruses. Current Topics inMicrobiology and Immunology 99:165–200
    [Google Scholar]
37. Wege H., Watanabe R., Ter Meulen V. 1984; Relapsing subacute demyelinating encephalomyelitis in rats inthe course of coronavirus JHM infection. Journal of Neuroimmunology 6:325–336
    [Google Scholar]
38. Yewdell J., Gerhard W. 1982; Delineation of four antigenic sites on a paramyxovirus glycoprotein via whichmonoclonal antibodies mediate distinct antiviral activities. Journal of Immunology 128:2670–2675
    [Google Scholar]